New molecular mechanisms of GH resistance

被引:36
作者
Rosenfeld, RG
Hwa, V
机构
[1] Lucile Packard Fdn Childrens Hlth, Palo Alto, CA 94304 USA
[2] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA
[3] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA
关键词
D O I
10.1530/eje.0.151S011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary growth hormone (GH) resistance describes growth failure in the presence of normal, or even elevated, GH secretion. In its classic form, the phenotype is identical to that of GH deficiency, and was originally described in association with defects of the GH receptor. With increasing understanding of the GH-insulin-like growth factor (IGF) axis, it has become apparent that GH resistance can result from either primary IGF deficiency (IGFD) or IGF resistance. Primary IGFD may be due to: (i) defects of the GH receptor, (ii) defects of post-GH receptor signaling or (iii) primary defects of IGF-I synthesis. IGF resistance may result from: (i) defects of the IGF receptor, (ii) defects of post-IGF receptor signaling, (iii) defects of IGF binding proteins or (iv) defects of the epiphyseal growth plate or of regulatory proteins involved in epiphyseal growth.
引用
收藏
页码:S11 / S15
页数:5
相关论文
共 29 条
[1]   IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation [J].
Abuzzahab, MJ ;
Schneider, A ;
Goddard, A ;
Grigorescu, F ;
Lautier, C ;
Keller, E ;
Kiess, W ;
Klammt, J ;
Kratzsch, J ;
Osgood, D ;
Pfäffle, R ;
Raile, K ;
Seidel, B ;
Smith, RJ ;
Chernausek, SD ;
Frank, GR ;
Kaplowitz, PB ;
Pescovitz, OH ;
Smith, EP .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (23) :2211-2222
[2]   The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter [J].
Ambrosio, R ;
Fimiani, G ;
Monfregola, J ;
Sanzari, E ;
De Felice, N ;
Salerno, MC ;
Pignata, C ;
D'Urso, M ;
Ursini, MV .
GENE, 2002, 285 (1-2) :311-318
[3]   A dominant-negative mutation of the growth hormone receptor causes familial short stature [J].
Ayling, RM ;
Ross, R ;
Towner, P ;
VonLaue, S ;
Finidori, J ;
Moutoussamy, S ;
Buchanan, CR ;
Clayton, PE ;
Norman, MR .
NATURE GENETICS, 1997, 16 (01) :13-14
[4]   ABSENCE OF SERUM GROWTH-HORMONE BINDING-PROTEIN IN PATIENTS WITH GROWTH-HORMONE RECEPTOR DEFICIENCY (LARON DWARFISM) [J].
DAUGHADAY, WH ;
TRIVEDI, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (13) :4636-4640
[5]   Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene [J].
Domené, HM ;
Bengolea, SV ;
Martinez, AS ;
Ropelato, MG ;
Pennisi, P ;
Scaglia, P ;
Heinrich, JJ ;
Jasper, HG .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (06) :570-577
[6]   A SINGLE AMINO-ACID SUBSTITUTION IN THE EXOPLASMIC DOMAIN OF THE HUMAN GROWTH-HORMONE (GH) RECEPTOR CONFERS FAMILIAL GH RESISTANCE (LARON-SYNDROME) WITH POSITIVE GH-BINDING ACTIVITY BY ABOLISHING RECEPTOR HOMODIMERIZATION [J].
DUQUESNOY, P ;
SOBRIER, ML ;
DURIEZ, B ;
DASTOT, F ;
BUCHANAN, CR ;
SAVAGE, MO ;
PREECE, MA ;
CRAESCU, CT ;
BLOUQUIT, Y ;
GOOSSENS, M ;
AMSELEM, S .
EMBO JOURNAL, 1994, 13 (06) :1386-1395
[7]  
Efstratiadis A, 1998, INT J DEV BIOL, V42, P955
[8]  
ESHET R, 1984, ISRAEL J MED SCI, V20, P8
[9]   Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children [J].
Freeth, JS ;
Silva, CM ;
Whatmore, AJ ;
Clayton, PE .
ENDOCRINOLOGY, 1998, 139 (01) :20-28
[10]   CHARACTERIZATION OF THE HUMAN GROWTH-HORMONE RECEPTOR GENE AND DEMONSTRATION OF A PARTIAL GENE DELETION IN 2 PATIENTS WITH LARON-TYPE DWARFISM [J].
GODOWSKI, PJ ;
LEUNG, DW ;
MEACHAM, LR ;
GALGANI, JP ;
HELLMISS, R ;
KERET, R ;
ROTWEIN, PS ;
PARKS, JS ;
LARON, Z ;
WOOD, WI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :8083-8087